These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14720055)

  • 1. Peptide receptor imaging: advances in the diagnosis of pulmonary diseases.
    Van de Wiele C; Signore A; Dierckx RA
    Am J Respir Med; 2002; 1(3):177-83. PubMed ID: 14720055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules.
    Blum JE; Handmaker H; Rinne NA
    Chest; 1999 Jan; 115(1):224-32. PubMed ID: 9925088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.
    Decristoforo C; Mather SJ; Cholewinski W; Donnemiller E; Riccabona G; Moncayo R
    Eur J Nucl Med; 2000 Sep; 27(9):1318-25. PubMed ID: 11007513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
    Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
    Behr TM; Béhé M; Becker W
    Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled peptides in the detection of deep venous thrombosis.
    Taillefer R
    Semin Nucl Med; 2001 Apr; 31(2):102-23. PubMed ID: 11330782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism.
    Babich JW; Tompkins RG; Graham W; Barrow SA; Fischman AJ
    J Nucl Med; 1997 Aug; 38(8):1316-22. PubMed ID: 9255175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
    Shapiro B
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled peptides in the diagnosis and therapy of oncological diseases.
    Weiner RE; Thakur ML
    Appl Radiat Isot; 2002 Nov; 57(5):749-63. PubMed ID: 12433051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends in peptide receptor radioligands.
    Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Andreae F; Kurtaran A; Dudczak R
    Q J Nucl Med; 2001 Jun; 45(2):153-9. PubMed ID: 11476164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging tumors with peptide-based radioligands.
    Behr TM; Gotthardt M; Barth A; Béhé M
    Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
    Blum J; Handmaker H; Lister-James J; Rinne N
    Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imaging of thromboembolism by scintigraphy with the 99m-technetium-labelled synthetic peptide P280].
    Lastoria S; Vergara E; Varrella P; Muto P; Acampa W; Caracò C; Salvatore M
    Radiol Med; 1995 Dec; 90(6):812-9. PubMed ID: 8685469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
    Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL
    Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
    Bernard BF; Krenning E; Breeman WA; Visser TJ; Bakker WH; Srinivasan A; de Jong M
    Nucl Med Commun; 2000 Nov; 21(11):1079-85. PubMed ID: 11192715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide.
    Lister-James J; Vallabhajosula S; Moyer BR; Pearson DA; McBride BJ; De Rosch MA; Bush LR; Machac J; Dean RT
    J Nucl Med; 1997 Jan; 38(1):105-11. PubMed ID: 8998163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
    Virgolini I; Traub T; Leimer M; Novotny C; Pangerl T; Ofluoglu S; Halvadjieva E; Smith-Jones P; Flores J; Li SR; Angelberger P; Havlik E; Andreae F; Raderer M; Kurtaran A; Niederle B; Dudczak R
    Q J Nucl Med; 2000 Mar; 44(1):50-8. PubMed ID: 10932601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
    Menda Y; Kahn D
    Semin Nucl Med; 2002 Apr; 32(2):92-6. PubMed ID: 11965604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic imaging of lower-extremity acute venous thrombosis.
    Carretta RF
    Adv Ther; 1998; 15(6):315-22. PubMed ID: 10351116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom.
    Knight LC; Baidoo KE; Romano JE; Gabriel JL; Maurer AH
    J Nucl Med; 2000 Jun; 41(6):1056-64. PubMed ID: 10855635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.